News
2008
New Partnership to Study the Genetic Causes of Diabetes, Obesity, and Other Diseases Announced
Motif BioSciences Inc and Imperial College London to Share Genetic Samples and Data under Research Collaboration
3 March 2008 - Motif BioSciences Inc., a specialized genetics company and an Amphion Innovations (LSE: AMP) Partner Company, announced today a new partnership with Imperial College London to study the genetic causes of important diseases including diabetes, obesity, and other metabolic and cardiovascular disorders. Under the new Research Partnership Agreement, signed today, Motif will partner with Professor Philippe Froguel of Imperial College, a pioneer in the genetics of metabolic disease, and will, with appropriate permission, gain immediate access to genetic samples and clinical data collected by Professor Froguel and his colleagues in Morocco.
2007
Amphion Innovations Partner Company Motif BioSciences Closes $1m Financing
April 05, 2007 - New York City - Amphion Innovations plc, a builder of companies in life sciences and technology, today announces that one of its partner companies, Motif BioSciences, Inc, a population genetics company in the Arabian Gulf Region, has raised $1 million in a Series C financing.
Amphion, which owns 42% of Motif, has invested $400,000 as part of this round. Motif is in the process of raising up to $3 million in capital and anticipates that it will conclude additional financing rounds in the coming months.
Population Genetics Yields New Insight Into Hard-To-Treat Illnesses (LifeSciTech)
January 2007
2006
Amphion Innovations plc Partner Company Motif BioSciences Announces Completion of $1.875 Million Financing and Commencement of Arabian Gulf Sampling Program
March 2, 2006 - New York City - Amphion Innovations plc's (LSE:AMP.L) partner company Motif BioSciences (Motif), a population genetics company focused on the discovery of genes causing common diseases by utilizing human genetic data from the Persian/Arabian Gulf region, announces that it has completed a $1.875 million financing and has received and begun analyzing the first sets of human genetic samples from the Arabian Gulf.